Delivery Order SPE2DB20D2104-SPE2DB25FMWXD
Award Date 7/30/25
Potential Completion Date 7/31/25
Potential Value $2.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on May 30, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) injectable medication. The contract, valued at $1,566.65 with a firm fixed-price structure, is scheduled for completion by June 2, 2025. This delivery order was competitively awarded with no set-aside designation and represents a child contract under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order valued at $36,378.29 for Ozempic 2 mg/dose (8 mg/3 mL) 3 mL vials from the Defense Medical Supply Chain on July 28, 2025. The contract is a firm fixed price delivery order with an ultimate completion date of July 29, 2025, and was awarded on a competitive basis without set-aside designation. This delivery order represents a child contract executed under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 25, 2025, by the Defense Logistics Agency to supply Ozempic 2 mg/dose (8 mg/3 ml) injectable medication. The contract, valued at $14,490.85, represents a firm fixed price delivery order with an ultimate completion date of August 26, 2025. This award was not designated as a set-aside contract and was competitively awarded through open competition. The...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $54,717.86 by the Defense Logistics Agency (DLA) on August 28, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract is characterized as a firm fixed price delivery order with an ultimate completion date of August 29, 2025, and was competitively awarded with no set-aside designation. This award is a child contract issued...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 20, 2025, by the Defense Logistics Agency for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL quantities, with a contract value of $11,350.99 and an ultimate completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procurement. The award represents a child order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on September 5, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 mL) in 3 mL vials. The contract, valued at $11,989.73, carries a firm fixed price and is classified as a non-set-aside, competitively awarded procurement. The delivery order is scheduled for completion by September 8, 2025, with the place of performance...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on June 4, 2025, by the Defense Logistics Agency (DLA) for the supply of Ozempic 0.25–0.5 mg/dose pens (3 mL). The contract, valued at $7,888.63, is structured as a firm fixed-price delivery order with no set-aside designation, reflecting competitive award procedures. Performance will be completed at the vendor's Conshohocken facility by the ultimate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency (DLA) on August 19, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 ml) 3 ml vials. This competitively awarded, non-set-aside firm fixed-price delivery order has a ceiling value of $2,015.92 and an ultimate completion date of August 20, 2025. The place of performance is located in Conshohocken, Pennsylvania, where...
- On September 8, 2025, the Defense Logistics Agency awarded a delivery order valued at $6,343.94 to AmerisourceBergen Drug Corp for the supply of Ozempic 1 mg/dose (4 mg/3 ml) in 3 ml vials. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026. The product will be delivered...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on September 18, 2025, for the supply of Ozempic 2 mg/dose (8 mg/3 ml) in 3 ml vials. The delivery order, valued at $33,789.66, represents a firm fixed price contract with an ultimate completion date of September 19, 2025, and was competitively awarded with no set-aside designation. Performance will occur at the vendor's...